We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+1.99%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$930M
AUM Growth
+$23.6M
(+2.6%)
Cap. Flow
+$25.6M
Cap. Flow
% of AUM
2.76%
Top 10 Holdings %
Top 10 Hldgs %
25.89%
Holding
569
New
53
Increased
139
Reduced
144
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ford
F
|
+$23.8M |
| 2 |
RTN
Raytheon Company
RTN
|
+$23.7M |
| 3 |
SNI
Scripps Networks Interactive, Inc Common Class A
SNI
|
+$23.5M |
| 4 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$23.4M |
| 5 |
Kimberly-Clark
KMB
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$23.1M |
| 2 |
AutoNation
AN
|
+$22.7M |
| 3 |
Public Service Enterprise Group
PEG
|
+$22.2M |
| 4 |
Pinnacle West Capital
PNW
|
+$22.1M |
| 5 |
Broadcom
AVGO
|
+$22.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 12.56% |
| 2 | Communication Services | 12.1% |
| 3 | Industrials | 10.62% |
| 4 | Consumer Staples | 10.55% |
| 5 | Materials | 8.66% |
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2015 Portfolio in Review
As of Q2 2015, Exane Derivatives held 569 positions worth $930M, up 2.6% from $906M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Exane Derivatives's Q2 2015 filing shows 53 new, 139 increased, 144 reduced and 48 closed positions. Its largest new stake was Raytheon Company: 225,989 shares worth $21.6M. The largest sale was Elevance Health, an estimated $23.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 12% a quarter earlier, followed by Communication Services and Industrials.
- Exane Derivatives's largest Q2 2015 buy was Raytheon Company: 225,989 shares worth $21.6M.
- Exane Derivatives added most to Ford in Q2 2015, an estimated $23.8M increase.
- Exane Derivatives's biggest Q2 2015 reduction was Broadcom, cutting an estimated $22.1M.
- Exane Derivatives fully exited Elevance Health in Q2 2015, selling an estimated $23.1M.
- Exane Derivatives's ten largest holdings make up 26% of its $930M portfolio in Q2 2015.
- Exane Derivatives opened 53 new positions and closed 48 in Q2 2015.
- Exane Derivatives's portfolio value rose 2.6% quarter-over-quarter to $930M.
Based on Exane Derivatives's 13F filing for Q2 2015, filed 14 Aug 2015.